Xponential (XPOF) Q3 2026 Earnings Call Transcript

Xponential Fitness reported Q3 revenue of $62.3 million, down 21% year over year, and adjusted EBITDA of $24.3 million, down 27%; North America same-store sales fell 7.5%. Management lowered 2026 net new studio opening guidance to 124–130 from approximately 150 and narrowed adjusted EBITDA guidance to $91–$94 million, while revenue guidance remained $250–$260 million. A board-led review of strategic alternatives, including a potential sale or merger, is ongoing; management also cited weaker boutique fitness spending, merchandise logistics issues and slower studio site execution.

Analysis

The key risk is a feedback loop between weaker studio demand and slower development: negative same-store sales and lower AUVs can lengthen franchisee paybacks, making landlords and franchisees less willing to commit even where XPOF has contractual license obligations. Thus, the license pipeline is not equivalent to near-term openings or royalty growth. More selective site approvals may protect unit economics over time, but further delays would defer equipment revenue and new royalty streams while putting the multi-year Club Pilates expansion ambition under pressure.

The website’s reported lift in lead submissions is an encouraging leading indicator, not evidence yet of better member conversion, retention, or studio sales. Verify whether lead gains convert into new memberships and whether comps stabilize; without that, technology spend risks improving funnel metrics without fixing franchisee economics. Consumer trade-down toward lower-cost gyms or home fitness could prolong the boutique slowdown, while logistics remediation may improve merchandise execution but is unlikely by itself to reverse the demand trend.

Near term, the strategic-alternatives review creates event-driven upside but also makes an outright short vulnerable to deal headlines. At roughly $521 million of long-term debt against $91–94 million of guided adjusted EBITDA, leverage limits room for prolonged operating weakness and may constrain transaction flexibility; treat this as a rough comparison, not a covenant measure. Over 1–3 months, watch opening cadence, comp trends, cash use, and any review outcome. Over 6–18 months, the thesis turns on franchisee returns and whether openings can grow without sacrificing site quality. Contrarian point: the development slowdown may be partly self-imposed discipline, not solely lost demand—but the sales decline means that interpretation needs proof.

Key Decisions for Investors

• Keep XPOF underweight pending evidence that weaker comps are stabilizing; avoid treating the board review as a dependable downside floor.
• For event exposure, consider a defined-risk XPOF put spread rather than a naked short, but only after checking option pricing and implied volatility; deal news can produce sharp upside gaps.
• Reassess after the next operating update: require improving same-store sales or clear new-member conversion, plus openings tracking toward revised guidance. Continued deterioration in comps, openings, or cash would falsify the stabilization case.
• Track whether merchandise fulfillment normalizes and whether the strategic review concludes; absent measurable operating improvement or a credible transaction, do not capitalize website lead growth as earnings recovery.